INS and metabolic syndrome: Despite a large proportion of patients being under SA at the time of FPI and an FG determination (60%), no differences in MetS criteria, MetS individual components, FPI, HOMA-RI, and the proportion of insulin resistant and severe insulin resistant patients were found between patients under SA treatment or were untreated, which suggests that our findings were not influenced by SA (Table 2).